NO20021203L - Glukopyronosidkonjugater av 2-(4-hydroksy-fenyl)-1-[4-(2-amin- 1-yl-etoksy)-benzyl]-1H-indoler-5-oler - Google Patents

Glukopyronosidkonjugater av 2-(4-hydroksy-fenyl)-1-[4-(2-amin- 1-yl-etoksy)-benzyl]-1H-indoler-5-oler

Info

Publication number
NO20021203L
NO20021203L NO20021203A NO20021203A NO20021203L NO 20021203 L NO20021203 L NO 20021203L NO 20021203 A NO20021203 A NO 20021203A NO 20021203 A NO20021203 A NO 20021203A NO 20021203 L NO20021203 L NO 20021203L
Authority
NO
Norway
Prior art keywords
glucopyronoside
amin
indoles
conjugates
ethoxy
Prior art date
Application number
NO20021203A
Other languages
English (en)
Other versions
NO322250B1 (no
NO20021203D0 (no
Inventor
Paul Christopher Miller
Michael David Collini
Bach Dinh Tran
Anita Wai-Yin Chan
Arkadiy Zinoviy Rubezhov
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of NO20021203D0 publication Critical patent/NO20021203D0/no
Publication of NO20021203L publication Critical patent/NO20021203L/no
Publication of NO322250B1 publication Critical patent/NO322250B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
NO20021203A 1999-09-13 2002-03-12 Glukopyronosidkonjugater av 2-(4-hydroksy-fenyl)-1-[4-(2-amin-1-yl-etoksy)-benzyl]-1H-indoler-5-oler NO322250B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39424099A 1999-09-13 1999-09-13
PCT/US2000/024738 WO2001019839A1 (en) 1999-09-13 2000-09-11 Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1h-indol-5-ols

Publications (3)

Publication Number Publication Date
NO20021203D0 NO20021203D0 (no) 2002-03-12
NO20021203L true NO20021203L (no) 2002-03-12
NO322250B1 NO322250B1 (no) 2006-09-04

Family

ID=23558135

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021203A NO322250B1 (no) 1999-09-13 2002-03-12 Glukopyronosidkonjugater av 2-(4-hydroksy-fenyl)-1-[4-(2-amin-1-yl-etoksy)-benzyl]-1H-indoler-5-oler

Country Status (25)

Country Link
EP (1) EP1212335B1 (no)
JP (1) JP2003509435A (no)
KR (1) KR100653570B1 (no)
CN (1) CN1196708C (no)
AR (1) AR025638A1 (no)
AT (1) ATE316093T1 (no)
AU (1) AU764436B2 (no)
BR (1) BR0013943A (no)
CA (1) CA2382683A1 (no)
CY (1) CY1104970T1 (no)
CZ (1) CZ298862B6 (no)
DE (1) DE60025630T2 (no)
DK (1) DK1212335T3 (no)
EA (1) EA005371B1 (no)
ES (1) ES2254215T3 (no)
HK (1) HK1044777B (no)
HU (1) HUP0202679A3 (no)
IL (2) IL148273A0 (no)
MX (1) MXPA02002654A (no)
NO (1) NO322250B1 (no)
NZ (1) NZ517645A (no)
PL (1) PL354179A1 (no)
TW (1) TWI287018B (no)
WO (1) WO2001019839A1 (no)
ZA (1) ZA200201876B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1406898B1 (en) * 2001-07-19 2005-04-06 Cv Therapeutics, Inc. Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
JP4847333B2 (ja) * 2004-09-06 2011-12-28 キッセイ薬品工業株式会社 排尿障害の予防又は治療薬
CA2758109A1 (en) * 2009-04-13 2010-10-21 Sandoz Ag Processes for the synthesis of bazedoxifene acetate and intermediates thereof
CN101857617A (zh) * 2010-04-28 2010-10-13 中国海洋大学 喹唑啉类糖衍生物及其制备方法和应用
CN102690225B (zh) * 2012-04-11 2014-12-24 南京友杰医药科技有限公司 巴多昔芬的合成方法
CN104798294B (zh) * 2012-11-22 2018-09-25 艾默生电气公司 电机、定子和压缩机，以及制造它们的方法
CN104151265B (zh) * 2013-05-13 2016-10-05 上海医药工业研究院 醋酸巴多昔芬中间体的制备方法
CN104725334A (zh) * 2013-12-20 2015-06-24 北京蓝贝望生物医药科技股份有限公司 (4-(2-(氮杂环庚烷-1-基)乙氧基)苯基)甲醇的制备方法
CN105085365B (zh) * 2014-05-12 2018-06-19 四川科伦药业股份有限公司 醋酸巴多昔芬及其中间体的制备方法
CN107033062B (zh) * 2017-03-24 2019-10-29 梯尔希（南京）药物研发有限公司 一种巴多昔芬衍生物的制备方法
CN107400087B (zh) * 2017-09-15 2019-12-13 济南美高生物医药科技有限公司 一种1-(2-(4-(氯甲基)苯氧基)乙基)氮杂环庚烷盐酸盐的制备方法
CN111196831B (zh) * 2020-01-20 2023-05-09 山西医科大学 一种呋喃酚葡萄糖醛酸结合物的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3821148A1 (de) * 1988-06-23 1989-12-28 Erwin Von Dr Angerer Aminoalkylindole, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
EP0639567A1 (en) * 1992-05-08 1995-02-22 Otsuka Pharmaceutical Factory, Inc. Indole derivative
GB9326332D0 (en) * 1993-12-23 1994-02-23 Karo Bio Indole derivatives
NZ281431A (en) * 1994-02-22 1997-09-22 Merrell Pharma Inc Alkylamide-substituted indole derivatives
US5567820A (en) * 1994-05-20 1996-10-22 Eli Lilly And Company Glucopyranoside benzothiophenes
DE4426625A1 (de) * 1994-07-27 1996-03-14 Schering Ag 2-Phenylindole, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
TW397821B (en) * 1996-04-19 2000-07-11 American Home Produits Corp 3-[4-(2-phenyl-indole-1-ylmethyl)-phenyl]-acrylamides and 2-phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol as well as pharmaceutical compositions of estrogenic agents thereof
PT802183E (pt) * 1996-04-19 2002-03-28 American Home Prod Agentes estrogenicos
PT1025077E (pt) * 1997-10-15 2007-05-31 Wyeth Corp Novas ariloxi-alquil-dialquilaminas
ID24568A (id) * 1997-11-06 2000-07-27 American Home Prod Kontrasepsi oral yang mengandung anti-estrogen plus progestin

Also Published As

Publication number Publication date
EA200200358A1 (ru) 2002-08-29
HK1044777B (en) 2006-04-13
EA005371B1 (ru) 2005-02-24
CZ2002881A3 (cs) 2003-01-15
DK1212335T3 (da) 2006-03-20
JP2003509435A (ja) 2003-03-11
MXPA02002654A (es) 2002-07-30
HUP0202679A2 (hu) 2003-01-28
NO322250B1 (no) 2006-09-04
PL354179A1 (en) 2003-12-29
IL148273A0 (en) 2002-09-12
WO2001019839A1 (en) 2001-03-22
AU764436B2 (en) 2003-08-21
NO20021203D0 (no) 2002-03-12
IL148273A (en) 2007-03-08
CY1104970T1 (el) 2010-03-03
ZA200201876B (en) 2003-08-27
HUP0202679A3 (en) 2003-04-28
AR025638A1 (es) 2002-12-04
CN1382151A (zh) 2002-11-27
KR20020027643A (ko) 2002-04-13
CN1196708C (zh) 2005-04-13
TWI287018B (en) 2007-09-21
EP1212335B1 (en) 2006-01-18
BR0013943A (pt) 2002-05-14
CA2382683A1 (en) 2001-03-22
CZ298862B6 (cs) 2008-02-27
HK1044777A1 (en) 2002-11-01
DE60025630T2 (de) 2006-08-10
ATE316093T1 (de) 2006-02-15
KR100653570B1 (ko) 2006-12-05
AU7128400A (en) 2001-04-17
ES2254215T3 (es) 2006-06-16
EP1212335A1 (en) 2002-06-12
NZ517645A (en) 2003-09-26
DE60025630D1 (de) 2006-04-06

Similar Documents

Publication Publication Date Title
DE60022699D1 (de) Einweg-Scharnierdämpfer
DE50013200D1 (de) Intravasale blutpumpe
NO20022727D0 (no) Adamantanderivater
NO20020191D0 (no) Applikator for reflexoterapi
NO20021203D0 (no) Glukopyronosidkonjugater av 2-(4-hydroksy-fenyl)-1-[4-(2-amin- 1-yl-etoksy)-benzyl]-1H-indoler-5-oler
ATE253561T1 (de) 2-(3,5-bis-trifluoromethyl-phenyl)-n-methyl-n-( - morpholin-4-yl-4-o-tolyl-pyridin-3-yl)- isobutyramid
DE60021170D1 (de) Verstärker
ATA25299A (de) Scharnier
IS5336A (is) 2-(4-Arýl eða heteróarýl-píperazín-1-ýlmetýl)-1H-indól afleiður
DE60025797D1 (de) Scharniervorrichtung
DE60040902D1 (de) Seidenpapier
ATE304590T1 (de) Imitator-zellulosebindungsdomäne
ATE299876T1 (de) Indolderivate
DK1055658T3 (da) Fremstilling af cis-1-{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphtalen-1-yl)phenoxy]ethyl-pyrrolidin
DE50006120D1 (de) Scharnier
NO20020306D0 (no) Indolderivater
ATE525362T1 (de) 2-(3-(4-(2-t-butyl-6-trifluormethylpyrimidin-4-
FR2796979B1 (fr) Gond
DE60045575D1 (de) Verstärker
DE50007103D1 (de) Scharnier
FI991185A0 (fi) Sarana
NO20015998D0 (no) Hengsel
FI19992245A7 (fi) Vahvistimen taajuuskompensointi
FI4037U1 (fi) Paperipyyhepakkaus
FI4245U1 (fi) Sarana

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees